PERCEPTIVE ADVISORS LLC Insider Trading Activity
Every SEC Form 4 transaction reported by PERCEPTIVE ADVISORS LLC, sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Is PERCEPTIVE ADVISORS LLC buying or selling?
PERCEPTIVE ADVISORS LLC reported 137 open-market buys ($1.1B) and 28 sells ($117.2M) across 165 Form 4 filings at 35 companies — a net buying position of $984.1M.
Source: SEC EDGAR Form 4
Key Statistics (as of Nov 13, 2025)
Insider sentiment
Net buyingNet insider flow of $984.1M in net buying, filed between Jan 18, 2018 – Nov 13, 2025.
Companies PERCEPTIVE ADVISORS LLC files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | ALDXAldeyra Therapeutics, Inc. | 17 |
| 2 | ATNXAthenex, Inc. | 14 |
| 3 | DOVADova Pharmaceuticals, Inc. | 10 |
| 4 | VBIVVBI Vaccines Inc/BC | 9 |
| 5 | ADMAADMA BIOLOGICS, INC. | 7 |
| 6 | AGRXAGILE THERAPEUTICS INC | 7 |
| 7 | FOLDAMICUS THERAPEUTICS INC | 7 |
| 8 | CERECerevel Therapeutics Holdings, Inc. | 6 |
| 9 | CRNXCrinetics Pharmaceuticals, Inc. | 6 |
| 10 | VYNEVYNE Therapeutics Inc. | 6 |
Recent PERCEPTIVE ADVISORS LLC transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Nov 13, 2025 | LYRA | 10% Owner | Sale | 45.9K | $182.5K |
| Nov 10, 2025 | LYRA | 10% Owner | Sale | 70.4K | $344.2K |
| May 1, 2025 | ACRV | 10% Owner | Sale | 736.8K | $1.0M |
| Apr 29, 2025 | ACRV | 10% Owner | Sale | 1.5M | $2.7M |
| Apr 7, 2025 | ALDX | 10% Owner | Sale | 3.4M | $4.8M |
| Feb 21, 2025 | SLDB | Director, 10% Owner | Purchase | 5.0M | $20.1M |
| Aug 14, 2024 | MGTX | Director, 10% Owner | Purchase | 1.3M | $5.0M |
| Apr 15, 2024 | ACRV | 10% Owner | Purchase | 2.4M | $20.0M |
| Apr 8, 2024 | ALDX | 10% Owner | Purchase | 178.0K | $833.9K |
| Apr 3, 2024 | ALDX | 10% Owner | Purchase | 504.3K | $1.9M |
| Feb 5, 2024 | ATXS | Director | Purchase | 2.5M | $30.0M |
| Jan 12, 2024 | SLDB | Director, 10% Owner | Purchase | 3.4M | $18.9M |
| Dec 29, 2023 | VRCA | 10% Owner | Purchase | 321.6K | $2.3M |
| Dec 29, 2023 | LONA | Director, 10% Owner | Purchase | 605.7K | $1.5M |
| Dec 27, 2023 | VRCA | 10% Owner | Purchase | 504.7K | $3.3M |
| Dec 22, 2023 | ATXS | Director | Purchase | 740.0K | $4.6M |
| Dec 19, 2023 | VRCA | 10% Owner | Purchase | 1.2M | $6.9M |
| Nov 14, 2023 | CRGX | Other | Purchase | 666.7K | $10.0M |
| Oct 18, 2023 | ALDX | 10% Owner | Sale | 2.8M | $4.5M |
| Oct 18, 2023 | ATXS | Director | Purchase | 1.1M | $7.0M |
| Oct 17, 2023 | CERE | Director | Purchase | 876.8K | $20.0M |
| Sep 28, 2023 | SLNO | 10% Owner | Purchase | 866.8K | $15.1M |
| Jun 6, 2023 | SLNO | 10% Owner | Purchase | 143.3K | $853.7K |
| Jun 2, 2023 | LYRA | Director, 10% Owner | Purchase | 3.6M | $9.0M |
| Jun 1, 2023 | SLNO | 10% Owner | Purchase | 35.0K | $188.2K |
Showing the 25 most recent filings of 165. Screen every filing.
PERCEPTIVE ADVISORS LLC insider trading FAQ
Is PERCEPTIVE ADVISORS LLC buying or selling?
Across 165 SEC Form 4 filings, PERCEPTIVE ADVISORS LLC reported 137 open-market purchases totaling $1.1B and 28 sales totaling $117.2M — a net buying position of $984.1M.
Which companies does PERCEPTIVE ADVISORS LLC file Form 4s for?
PERCEPTIVE ADVISORS LLC has reported insider transactions at 35 companies, most often Aldeyra Therapeutics, Inc. (ALDX), Athenex, Inc. (ATNX), Dova Pharmaceuticals, Inc. (DOVA), VBI Vaccines Inc/BC (VBIV), ADMA BIOLOGICS, INC. (ADMA).
How far back does PERCEPTIVE ADVISORS LLC's filing history go?
Trabud holds PERCEPTIVE ADVISORS LLC's SEC Form 4 filings from Jan 18, 2018 – Nov 13, 2025, sourced directly from SEC EDGAR.
Where does Trabud get PERCEPTIVE ADVISORS LLC's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track PERCEPTIVE ADVISORS LLC and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener